Works in Alimentary Pharmacology & Therapeutics, 2020, Vol 52, Issue 11/12


Results: 29
    1

    Issue Information.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1625, doi. 10.1111/apt.16168
    Publication type:
    Article
    2

    Corrigendum.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1771, doi. 10.1111/apt.16126
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Real‐world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate‐treated chronic hepatitis B pregnant patients in North America.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1707, doi. 10.1111/apt.16123
    By:
    • Samadi Kochaksaraei, Golasa;
    • Castillo, Eliana;
    • Sadler, Matthew D.;
    • Seow, Cynthia H.‐T.;
    • Barkema, Herman W.;
    • Martin, Steven R.;
    • Israelson, Heidi;
    • Pinto, Jacqueline;
    • Williams, Sarah;
    • Aspinall, AIexander I.;
    • Stinton, Laura M.;
    • Borman, Meredith A.;
    • Burak, Kelly W.;
    • Swain, Mark G.;
    • Congly, Stephen E.;
    • Lee, Samuel S.;
    • Shaheen, Abdel Aziz;
    • Coffin, Carla S.
    Publication type:
    Article
    10
    11
    12

    Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1658, doi. 10.1111/apt.16119
    By:
    • Panaccione, Remo;
    • Danese, Silvio;
    • Sandborn, William J.;
    • O'Brien, Christopher D.;
    • Zhou, Yiying;
    • Zhang, Hongyan;
    • Adedokun, Omoniyi J.;
    • Tikhonov, Ilia;
    • Targan, Stephan;
    • Abreu, Maria T.;
    • Hisamatsu, Tadakazu;
    • Scherl, Ellen J.;
    • Leong, Rupert W.;
    • Rowbotham, David S.;
    • Arasaradnam, Ramesh P.;
    • Sands, Bruce E.;
    • Marano, Colleen
    Publication type:
    Article
    13
    14
    15

    Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1695, doi. 10.1111/apt.16116
    By:
    • Hu, Tsung‐Hui;
    • Yueh‐Hsia Chiu, Sherry;
    • Tseng, Po‐Lin;
    • Chen, Chien‐Hung;
    • Lu, Sheng‐Nan;
    • Wang, Jing‐Houng;
    • Hung, Chao‐Hung;
    • Kee, Kwong‐Ming;
    • Lin, Ming‐Tsung;
    • Chang, Kuo‐Chin;
    • Lin, Meng‐Chih;
    • Chien, Rong‐Nan
    Publication type:
    Article
    16
    17
    18

    Collagen proportionate area predicts clinical outcomes in patients with alcohol‐related liver disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1728, doi. 10.1111/apt.16111
    By:
    • Israelsen, Mads;
    • Guerrero Misas, Marta;
    • Koutsoumourakis, Anastasios;
    • Huang, Yi;
    • Thiele, Maja;
    • Hall, Andrew;
    • Rasmussen, Ditlev;
    • Covelli, Claudia;
    • Buzzetti, Elena;
    • Prat, Laura Iogna;
    • Roccarina, Davide;
    • Detlefsen, Sönke;
    • Luong, Tu Vinh;
    • Quaglia, Alberto;
    • Krag, Aleksander;
    • Jeffrey, Gary;
    • Pinzani, Massimo;
    • Tsochatzis, Emmanuel A.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29